Literature DB >> 17570530

Genotypic diversity of imipenem resistant isolates of Acinetobacter baumannii in Spain.

Jesús Oteo1, Carmen García-Estébanez, Silvia Migueláñez, José Campos, Sara Martí, Jordi Vila, Maria Angeles Domínguez, Fernando Docobo, Nieves Larrosa, Alvaro Pascual, Vicente Pintado, Pere Coll.   

Abstract

OBJECTIVES: To investigate relevant clinical and microbiological features of Acinetobacter baumannii in Spanish hospitals and to establish the genotypic diversity of imipenem resistant isolates.
MATERIAL AND METHODS: Seven Spanish hospitals collected 354 consecutive isolates that were subjected to antimicrobial susceptibility testing by standard methods. Further genetic analysis was determined by PFGE in a subset of 135 isolates from three hospitals selected because each of them presented high-, medium-, and low imipenem resistance rates.
RESULTS: Most isolates were from males (61.9%), age >65 years (52.3%), admitted to ICU (35.6%), and isolated from the respiratory tract (31.1%). Rates of carbapenem- and sulbactam resistance were 44.9% and 39.9%, respectively. Colistin was active against multiresistant isolates. Rates of imipenem resistance varied according to individual hospital (average: 43.8%; range: 13.5%-85.0%), medical department (more prevalent in ICU), and clinical sample (higher in isolates from the respiratory tract). Of the 135 isolates studied by PFGE (64 of them imipenem-resistant), 115 (85.1%) were distributed among 14 clusters and 20 were unrelated. Of the imipenem-resistant isolates, 45 (70.3%) belonged to six clusters that also had imipenem- susceptible isolates; 14 constituted four exclusive clusters, and five were unrelated.
CONCLUSIONS: Acquisition of imipenem resistance in A. baumannii is likely due to both clonal and non-clonal dissemination; resistance rates strongly vary between different hospitals and even between different hospital departments.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17570530     DOI: 10.1016/j.jinf.2007.04.009

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  5 in total

1.  Horizontal gene transfer and assortative recombination within the Acinetobacter baumannii clinical population provide genetic diversity at the single carO gene, encoding a major outer membrane protein channel.

Authors:  María Alejandra Mussi; Adriana S Limansky; Verónica Relling; Pablo Ravasi; Adrián Arakaki; Luis A Actis; Alejandro M Viale
Journal:  J Bacteriol       Date:  2011-07-15       Impact factor: 3.490

2.  Multidrug resistant acinetobacter.

Authors:  Vikas Manchanda; Sinha Sanchaita; Np Singh
Journal:  J Glob Infect Dis       Date:  2010-09

3.  Carbapenem resistance and Acinetobacter baumannii in Senegal: the paradigm of a common phenomenon in natural reservoirs.

Authors:  Marie Kempf; Jean-Marc Rolain; Georges Diatta; Saïd Azza; Bissoum Samb; Oleg Mediannikov; Amy Gassama Sow; Seydina M Diene; Florence Fenollar; Didier Raoult
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

Review 4.  Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens.

Authors:  Vishvanath Tiwari; Ranita Roy; Monalisa Tiwari
Journal:  Front Microbiol       Date:  2015-06-18       Impact factor: 5.640

5.  Chimeric vaccine designs against Acinetobacter baumannii using pan genome and reverse vaccinology approaches.

Authors:  Fatima Shahid; Tahreem Zaheer; Shifa Tariq Ashraf; Muhammad Shehroz; Farha Anwer; Anam Naz; Amjad Ali
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.